Scientists comment on MHRA saying ‘Donanemab licensed for treatment of Alzheimer’s disease in some adults’, and NICE draft guidance saying … read more
A study published in The BMJ looks at the association between certain diabetes drugs and lower risk of developing dementia. … read more
Scientists comment on both MHRA and NICE news on lecanemab for Alzheimer’s disease. Fiona Carragher, Chief Policy and Research … read more
A perspective article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association looks at challenges for new Alzheimer’s drugs. … read more
A report published in the Lancet looks at dementia prevention, intervention and care. Dr Sarah-Naomi James, Senior Research Fellow, MRC Unit … read more
A conference abstract presented at the Alzheimer’s Association International Conference looks at red meat intake and dementia risk. Dr Richard … read more
Scientists react to findings presented at the Alzheimer’s Association International Conference (AAIC) 2024 about continuous treatment with lecanemab. Prof … read more
A conference abstract at the Alzheimer’s Association International Conference looks at weight loss drug liraglutide and Alzheimer’s disease. Dr … read more
Scientist comment on the EMA decision on the use of lecanemab for Alzheimer’s disease. Prof Robert Howard, Professor of … read more
A study published in Nature Medicine looks at the shingles vaccine and risk of dementia. Prof Tara Spires-Jones, FMedSci, President … read more
Shingles is a painful and serious condition afflicting many elderly people. It is caused by the Herpes zoster virus that … read more
A study published in Nature Communications looks at identifying blood biomarkers to predict Parkinson’s disease. Professor Ray Chaudhuri, Professor of Movement … read more
A study published in Nature Mental Health looks at the possibility of early dementia prediction from brain scans. Dr Julia … read more
A study published in Nature Medicine looks at the genetic variants and Alzheimer’s disease. Prof Jonathan Schott, Chief Medical Officer at … read more
A study published in The BMJ looks at antipsychotic use in people with dementia. Dr Richard Oakley, Associate Director of … read more
A study published in Nature Medicine looks at Prasinezumab and motor progression in Parkinson’s disease. The following comments were provided … read more
Scientists react to news that the FDA are delaying a decision on the Alzheimer’s drug Donanemab. Prof Robert Howard, … read more
A study published in Nature Aging looks at possible plasma protein biomarkers for dementia risk. Dr Sheona Scales, Director of Research … read more
A study published in Neurology looks at erectile dysfunction drugs and risk of Alzheimer’s Disease. Dr Francesco Tamagnini, Neurophysiologist at the … read more
A study published in Nature Medicine looks at Alzheimer’s Disease in recipients of cadaveric pituitary-derived growth hormone. Dr Richard Oakley, Associate … read more
